Cornelia Lass‐flörl
#128,870
Most Influential Person Now
Cornelia Lass‐flörl's AcademicInfluence.com Rankings
Cornelia Lass‐flörlphilosophy Degrees
Philosophy
#6169
World Rank
#9163
Historical Rank
Logic
#3358
World Rank
#4505
Historical Rank
Cornelia Lass‐flörlbiology Degrees
Biology
#8351
World Rank
#11414
Historical Rank
Microbiology
#422
World Rank
#475
Historical Rank
Download Badge
Philosophy Biology
Cornelia Lass‐flörl's Degrees
- Doctorate Medicine Medical University of Innsbruck
Why Is Cornelia Lass‐flörl Influential?
(Suggest an Edit or Addition)Cornelia Lass‐flörl's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (2012) (1017)
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (2018) (801)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. (2014) (710)
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗ (2008) (579)
- Changing epidemiology of systemic fungal infections. (2008) (488)
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update (2011) (474)
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (2020) (454)
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (2016) (424)
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. (2014) (387)
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). (2012) (371)
- The changing face of epidemiology of invasive fungal disease in Europe (2009) (368)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. (2012) (343)
- Antifungal drug resistance among Candida species: mechanisms and clinical impact (2015) (311)
- Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus (2015) (285)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). (2012) (280)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. (2012) (267)
- COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment (2020) (263)
- Epidemiology and outcome of infections due to Aspergillus terreus: 10‐year single centre experience (2005) (261)
- Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. (2012) (252)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. (2014) (251)
- Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion (2020) (248)
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain (2010) (232)
- In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. (1998) (222)
- The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. (2007) (217)
- PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue (2005) (214)
- Triazole Antifungal Agents in Invasive Fungal Infections (2011) (211)
- Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. (2009) (208)
- Human Protothecosis (2007) (208)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole (2012) (200)
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? (2013) (195)
- IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis (2016) (190)
- Forty-one recent cases of invasive zygomycosis from a global clinical registry. (2009) (177)
- Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains. (1997) (165)
- Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media (2009) (164)
- Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing (2008) (143)
- Diagnosing COVID-19-associated pulmonary aspergillosis (2020) (142)
- Zygomycosis: conventional laboratory diagnosis. (2009) (138)
- Proposed nomenclature for Pseudallescheria, Scedosporium and related genera (2014) (136)
- Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. (2012) (133)
- Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul‐Ehrlich‐Society for Chemotherapy (2011) (129)
- Detection and investigation of invasive mould disease. (2011) (128)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. (2012) (123)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine (2012) (123)
- Potential Basis for Amphotericin B Resistance in Aspergillus terreus (2008) (121)
- Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing (2008) (116)
- Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp. (2013) (116)
- Mucormycosis--from the pathogens to the disease. (2014) (116)
- Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of COVID-19 (2020) (116)
- 68Ga-Siderophores for PET Imaging of Invasive Pulmonary Aspergillosis: Proof of Principle (2010) (112)
- The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. (2010) (109)
- Diagnosing Invasive Aspergillosis during Antifungal Therapy by PCR Analysis of Blood Samples (2004) (108)
- Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies (2001) (108)
- Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins (2008) (107)
- Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging (2012) (106)
- EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. (2012) (104)
- Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology (2019) (103)
- Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. (2000) (103)
- Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay (2011) (99)
- Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies (2008) (98)
- Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole (2014) (97)
- Gliotoxin production by clinical and environmental Aspergillus fumigatus strains. (2008) (97)
- How to: interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). (2020) (95)
- A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis (2017) (95)
- Laboratory diagnosis of mucormycosis: current status and future perspectives. (2014) (95)
- Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries (2013) (95)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. (2012) (89)
- The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin (2021) (86)
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method (2013) (84)
- Platelets as immune cells in infectious diseases. (2013) (84)
- EUCAST technical note on fluconazole. (2008) (84)
- Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis (2021) (83)
- Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages (2008) (82)
- Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. (2001) (80)
- Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium (2020) (78)
- In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing (2009) (77)
- Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales (2015) (76)
- HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. (2001) (75)
- Primary antifungal prophylaxis in leukaemia patients (2007) (73)
- Aspergillus alabamensis, a New Clinically Relevant Species in the Section Terrei (2009) (71)
- Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method (2016) (71)
- Studies of In Vitro Activities of Voriconazole and Itraconazole against Aspergillus Hyphae Using Viability Staining (2001) (70)
- Changes in the epidemiological landscape of invasive mould infections and disease (2017) (70)
- Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method (2013) (70)
- Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples (2012) (68)
- Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. (2013) (68)
- In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing (2008) (68)
- Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia (2009) (67)
- Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. (2008) (66)
- Mechanism of Human Immunodeficiency Virus-Induced Complement Expression in Astrocytes and Neurons (2002) (66)
- Minireview: host defence in invasive aspergillosis (2013) (66)
- Human platelets attenuate Aspergillus species via granule-dependent mechanisms. (2008) (66)
- In Vitro Antifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries (2009) (65)
- Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients (2015) (63)
- Recent trends in molecular diagnostics of yeast infections: from PCR to NGS (2019) (63)
- New Insight into Amphotericin B Resistance in Aspergillus terreus (2013) (63)
- European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. (2012) (62)
- In vitro susceptibility testing in fungi: a global perspective on a variety of methods (2010) (61)
- Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature (2011) (61)
- Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro (2008) (61)
- EUCAST technical note on voriconazole and Aspergillus spp. (2013) (61)
- Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. (2006) (61)
- Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections (2017) (60)
- Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi‐centre study (2012) (58)
- Complement and platelets: Mutual interference in the immune network. (2015) (58)
- Improving outcome of fungal diseases – Guiding experts and patients towards excellence (2017) (58)
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project (2019) (58)
- Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. (2001) (57)
- Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment (2014) (57)
- In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration. (2012) (57)
- Complement and fungal pathogens: an update (2008) (57)
- Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples. (2016) (56)
- Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance (2015) (56)
- Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. (2016) (56)
- Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase (2017) (55)
- Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? (2018) (55)
- The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens (2020) (55)
- Improvement of Detection of Bacterial Pathogens in Normally Sterile Body Sites with a Focus on Orthopedic Samples by Use of a Commercial 16S rRNA Broad-Range PCR and Sequence Analysis (2012) (55)
- Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies (2011) (54)
- Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods (2007) (53)
- EUCAST technical note on anidulafungin. (2011) (53)
- Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline. (2001) (53)
- Epidemiology of Invasive Fungal Infections in the Mediterranean Area (2011) (53)
- Aspergillus fumigatus and aspergillosis: From basics to clinics (2021) (53)
- Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis in Solid Organ Transplant Patients: A Semiprospective Multicenter Study (2014) (53)
- Utility of PCR in Diagnosis of Invasive Fungal Infections: Real-Life Data from a Multicenter Study (2012) (52)
- EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management (2018) (51)
- Molecular Typing of Aspergillus terreus Isolates Collected in Houston, Texas, and Innsbruck, Austria: Evidence of Great Genetic Diversity (2007) (51)
- How to make a fast diagnosis in invasive aspergillosis. (2019) (50)
- Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013 (2014) (49)
- Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods (2018) (49)
- Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients (1999) (49)
- Human Immunodeficiency Virus Type 1 Induces Expression of Complement Factors in Human Astrocytes (2001) (49)
- Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. (2013) (49)
- Diagnostic accuracy of the Aspergillus‐specific bronchoalveolar lavage lateral‐flow assay in haematological malignancy patients (2015) (49)
- Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes. (2013) (48)
- Platelet immunology in fungal infections (2014) (48)
- EUCAST breakpoints for antifungals. (2010) (48)
- Identification of Aspergillus fumigatus Surface Components That Mediate Interaction of Conidia and Hyphae With Human Platelets. (2015) (47)
- Fusarium verticillioides Abscess of the Nasal Septum in an Immunosuppressed Child: Case Report and Identification of the Morphologically Atypical Fungal Strain (2005) (46)
- Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together (2018) (46)
- Disseminated Infection with Prototheca zopfii after Unrelated Stem Cell Transplantation for Leukemia (2004) (46)
- YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries. (2019) (46)
- A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. (2008) (44)
- First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey (2020) (44)
- Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species. (2016) (44)
- In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method. (2016) (43)
- Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution (2003) (43)
- EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole (2014) (42)
- Secretion of a fungal protease represents a complement evasion mechanism in cerebral aspergillosis. (2010) (42)
- Cross-sectional point prevalence survey to study the environmental contamination of nosocomial pathogens in intensive care units under real-life conditions. (2018) (41)
- Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. (2021) (41)
- Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata (2018) (41)
- Potential antifungal effects of human platelets against zygomycetes in vitro. (2009) (41)
- Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints. (2012) (41)
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method (2013) (41)
- Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment (2018) (40)
- Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis (2015) (40)
- Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis (2012) (40)
- IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. (2017) (40)
- Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis (2019) (40)
- HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. (2004) (39)
- Erratum: The European Committee on antimicrobial susceptibility testing - Subcommittee on antifungal susceptibility testing (EUCAST-AFST)*. EUCAST technical note on fluconazole (Clinical Microbiology and Infection (2008) vol. 14(2) (193-195)) (2009) (39)
- Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method. (2003) (39)
- Blocking Hsp70 Enhances the Efficiency of Amphotericin B Treatment against Resistant Aspergillus terreus Strains (2015) (39)
- Contamination during removal of cement in revision hip arthroplasty. A cadaver study using ultrasound and high-speed cutters. (2003) (38)
- Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. (1999) (38)
- Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols (2010) (38)
- Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real‐life data from a retrospective single‐centre observational study (2015) (37)
- Aspergillus terreus: Novel lessons learned on amphotericin B resistance. (2018) (37)
- In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus. (2013) (37)
- Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug? (2017) (36)
- Bacterial contamination of needles used for spinal and epidural anaesthesia. (1999) (36)
- Candida albicans Hgt1p, a multifunctional evasion molecule: complement inhibitor, CR3 analogue, and human immunodeficiency virus-binding molecule. (2011) (35)
- Susceptibility testing in Aspergillus species complex. (2014) (35)
- In vitro susceptibility testing in Aspergillus species: an update. (2010) (35)
- Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis. (2013) (35)
- Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells (2015) (35)
- A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. (2017) (34)
- Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. (2011) (34)
- Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium (2015) (34)
- Natural killer cell‐mediated damage of clinical isolates of mucormycetes (2016) (33)
- EUCAST technical note on Amphotericin B. (2011) (33)
- Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions (2008) (32)
- C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia (2021) (32)
- Serology anno 2021 - fungal infections: from invasive to chronic. (2021) (32)
- Invasive pulmonary mycosis due to Penicillium chrysogenum: a new invasive pathogen. (2013) (32)
- Current Challenges in the Diagnosis of Fungal Infections. (2017) (32)
- Clinical evaluation of Aspergillus‐PCR for detection of invasive aspergillosis in immunosuppressed patients (2005) (31)
- Environmental and Body Contamination Through Aerosols Produced by High-Speed Cutters in Lumbar Spine Surgery (2001) (31)
- Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached? (2020) (31)
- Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples. (2019) (31)
- EUCAST technical note on posaconazole. (2011) (30)
- Up-date on diagnostic strategies of invasive aspergillosis. (2013) (30)
- Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation. (2012) (30)
- Phylogenetic Relationships Matter: Antifungal Susceptibility among Clinically Relevant Yeasts (2013) (29)
- Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates (2020) (29)
- Invasive pulmonary Aspergillosis in organ transplants--Focus on lung transplants. (2016) (29)
- Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients (2021) (29)
- In vitro susceptibility‐testing in Aspergillus species (2008) (29)
- Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes. (2020) (29)
- Detection of Aspergillus in lung and other tissue samples using the MycAssay Aspergillus real-time PCR kit. (2011) (29)
- Treatment of Infections Due to Aspergillus terreus Species Complex (2018) (28)
- The role of complement in invasive fungal infections (2004) (28)
- Bronchoalveolar Lavage Fluid (1,3)&bgr;-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study (2015) (28)
- Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling (2017) (28)
- In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex (2018) (28)
- Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter. (2005) (27)
- Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro. (2003) (27)
- Aerosols produced by high-speed cutters in cervical spine surgery: extent of environmental contamination (2001) (27)
- Etest Cannot Be Recommended for In Vitro Susceptibility Testing of Mucorales (2015) (27)
- Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro (2006) (26)
- New insights into invasive aspergillosis--from the pathogen to the disease. (2013) (26)
- Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer’s recommendations (2002) (26)
- Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures (2020) (25)
- De Novo Whole-Genome Sequence and Genome Annotation of Lichtheimia ramosa (2014) (25)
- The Mediterranean red alga Asparagopsis taxiformis has antifungal activity against Aspergillus species (2013) (25)
- Generation of Human Monocyte-derived Dendritic Cells from Whole Blood. (2016) (25)
- Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes. (2012) (25)
- Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values (2018) (24)
- Diagnosing and monitoring of invasive aspergillosis during antifungal therapy by polymerase chain reaction: an experimental study in mice. (2003) (24)
- Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy (2010) (24)
- Complement synthesis and activation in the brain of SIV-infected monkeys (2004) (24)
- Contamination Risk of the Surgical Team Through ROBODOC®’s High-Speed Cutter (2001) (24)
- The Polypore Mushroom Irpex lacteus, a New Causative Agent of Fungal Infections (2005) (24)
- Respiratory specimens and the diagnostic accuracy of aspergillus lateral flow assays (LFA-IMMYTM): real life data from a multicenter study. (2019) (24)
- Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei (2018) (24)
- Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro. (2005) (23)
- Treatment of drug-resistant Aspergillus infection (2015) (23)
- First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation. (2008) (22)
- Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells (2007) (22)
- Current issues in the clinical management of invasive candida infections – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009 (2011) (22)
- Do high MICs predict the outcome in invasive fusariosis? (2020) (22)
- Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure (2020) (22)
- Inflammation marker 7,8-dihydroneopterin induces apoptosis of neurons and glial cells: a potential contribution to neurodegenerative processes. (2000) (21)
- In Vitro Activities of Amphotericin B and Voriconazole against Aleurioconidia from Aspergillus terreus (2005) (21)
- Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge? (2020) (21)
- Complement induction and complement evasion in patients with cerebral aspergillosis. (2008) (21)
- Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. (2004) (21)
- Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology (2019) (21)
- Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New (2021) (21)
- Promising immunotherapy against fungal diseases (2017) (21)
- Geographically predominant genotypes of Aspergillus terreus species complex in Austria: s microsatellite typing study. (2016) (21)
- Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients (2001) (21)
- Importance of the terminal complement components for immune defence against Candida. (2003) (21)
- Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. (2013) (20)
- Antifungal resistance in Aspergillus terreus: A current scenario. (2019) (20)
- Gliotoxin as putative virulence factor and immunotherapeutic target in a cell culture model of cerebral aspergillosis. (2011) (20)
- Alternaria alternata soft tissue infection in a forearm transplant recipient. (2007) (20)
- A point prevalence survey on hand hygiene, with a special focus on Candida species. (2016) (20)
- Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge (2021) (20)
- Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii. (2014) (20)
- Invasive candidiasis: future directions in non-culture based diagnosis (2017) (20)
- Candida albicans Factor H Binding Molecule Hgt1p – A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human Neutrophils (2019) (20)
- Mammary candidiasis: molecular-based detection of Candida species in human milk samples (2016) (19)
- Long term complications following 54 consecutive lung transplants. (2016) (19)
- High-quality endoscope reprocessing decreases endoscope contamination. (2018) (19)
- Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey. (2011) (19)
- Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria (2017) (19)
- Interlaboratory comparison of PCR‐based identification of Candida and Aspergillus DNA in spiked blood samples (2012) (19)
- Chronic paracoccidioidomycosis in a female patient in Austria (2004) (19)
- Characterization of methicillin-resistant Staphylococcus aureus from Ulaanbaatar, Mongolia (2006) (19)
- Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. (2019) (19)
- The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B. (2019) (19)
- Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance (2017) (18)
- Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit (2018) (18)
- Antifungal activity of the local complement system in cerebral aspergillosis. (2005) (18)
- Aspergillus osteoarthritis in acute lymphoblastic leukemia (1999) (18)
- Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement (2020) (18)
- In vitro studies on the activity of amphotericin B and lipid‐based amphotericin B formulations against Aspergillus conidia and hyphae (2002) (18)
- Antifungal properties of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. (2002) (17)
- Anidulafungin for the treatment of invasive candidiasis. (2011) (17)
- Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience (2017) (17)
- Candida and Complement: New Aspects in an Old Battle (2020) (17)
- Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells (2016) (17)
- Recent Increase in the Prevalence of Fluconazole-Non-susceptible Candida tropicalis Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and Genotyping (2020) (17)
- In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes (2007) (16)
- Culture supernatants of patient-derived Aspergillus isolates have toxic and lytic activity towards neurons and glial cells. (2000) (16)
- Invasive Fungal Infections Supplement ESCMID / ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast Infections (2013) (16)
- Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro (2001) (16)
- The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey. (2022) (16)
- Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. (2007) (16)
- Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro. (2003) (16)
- Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes. (2000) (16)
- Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility (2013) (16)
- Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods. (2009) (16)
- Aspergillus terreus: how inoculum size and host characteristics affect its virulence. (2012) (15)
- Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients (2019) (15)
- Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay (2019) (15)
- Genotyping of Paracoccidioides brasiliensis directly from paraffin embedded tissue. (2008) (15)
- Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis (2016) (14)
- Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis (2016) (14)
- HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion. (2003) (14)
- Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis. (2019) (14)
- Novel Antifungal Agents and Their Activity against Aspergillus Species (2020) (14)
- CHD1 Contributes to Intestinal Resistance against Infection by P. aeruginosa in Drosophila melanogaster (2012) (14)
- Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells. (2015) (14)
- The leucine biosynthetic pathway is crucial for adaptation to iron starvation and virulence in Aspergillus fumigatus (2019) (14)
- Generation of A Mucor circinelloides Reporter Strain—A Promising New Tool to Study Antifungal Drug Efficacy and Mucormycosis (2018) (14)
- Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope® - Global Registry for Emerging Fungal Infections. (2020) (14)
- Current issues in the clinical management of invasive aspergillosis – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009 (2011) (14)
- Human seroprevalence against Borrelia burgdorferi sensu lato in two comparable regions of the eastern Alps is not correlated to vector infection rates. (2015) (14)
- Susceptibility Profiles of Amphotericin B and Posaconazole against Clinically Relevant Mucorales Species under Hypoxic Conditions (2014) (14)
- Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. (2011) (14)
- Candida: Platelet Interaction and Platelet Activity in vitro (2018) (14)
- Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern (2022) (14)
- Interaction of Platelets and Anidulafungin against Aspergillus fumigatus (2012) (13)
- Antifungal susceptibility profiles of rare ascomycetous yeasts. (2019) (13)
- Airborne fungus exposure prior to hospitalisation as risk factor for mould infections in immunocompromised patients (2012) (13)
- EUCAST Testing of Isavuconazole Susceptibility in Aspergillus: Comparison of Results for Inoculum Standardization Using Conidium Counting versus Optical Density (2014) (13)
- Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination (2009) (13)
- A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women (2021) (13)
- Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis. (2013) (13)
- Bacterial contamination of solutions for parenteral administration for single- and multiple-dose vials after multiple use in the hospital (2007) (13)
- Sterol Composition of Clinically Relevant Mucorales and Changes Resulting from Posaconazole Treatment (2018) (13)
- Differential gene expression in Aspergillus fumigatus induced by human platelets in vitro (2015) (12)
- ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies (2019) (12)
- Risk assessment of transfusion‐associated babesiosis in Tyrol: appraisal by seroepidemiology and polymerase chain reaction (2014) (12)
- Evaluation of a Novel Mitochondrial Pan-Mucorales Marker for the Detection, Identification, Quantification, and Growth Stage Determination of Mucormycetes (2019) (12)
- A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients (2018) (12)
- Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients (2019) (12)
- Effect of Reduced Oxygen on the Antifungal Susceptibility of Clinically Relevant Aspergilli (2014) (12)
- High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients (2018) (12)
- MixInYeast: A Multicenter Study on Mixed Yeast Infections (2020) (12)
- ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia (2021) (11)
- Caspofungin: when and how? The microbiologist’s view (2012) (11)
- Susceptibility Screening of Hyphae-Forming Fungi with a New, Easy, and Fast Inoculum Preparation Method (2012) (11)
- Biopsy Procedures for Molecular Tissue Diagnosis of Invasive Fungal Infections (2011) (11)
- In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice? (2010) (11)
- Triazole-resistant candidaemia following posaconazole exposure. (2009) (11)
- Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action (2022) (11)
- Antifungal susceptibility of yeast bloodstream isolates collected during a 10‐year period in Austria (2019) (10)
- Commercial Molecular Tests for Fungal Diagnosis from a Practical Point of View. (2017) (10)
- β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells (2018) (10)
- Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans (2019) (10)
- Candidemia Among Coronavirus Disease 2019 Patients in Turkey Admitted to Intensive Care Units: A Retrospective Multicenter Study (2022) (10)
- The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles (2019) (10)
- Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. (2010) (10)
- Microbial challenge tests on nonradioactive TiO2-based 68Ge/68Ga generator columns (2012) (10)
- Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts. (2020) (10)
- Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development (2021) (10)
- Cryptic species of Aspergillus section Terrei display essential physiological features to cause infection and are similar in their virulence potential in Galleria mellonella (2019) (9)
- Benefits of risk‐adapted and mould‐specific antifungal prophylaxis in childhood leukaemia (2020) (9)
- [Vancomycin resistant enterococci in Austria]. (1997) (9)
- Increased serum amylase and lipase in fructose malabsorbers. (2001) (9)
- In Vitro Antifungal Susceptibility of Candida glabrata to Caspofungin and the Presence of FKS Mutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection (2014) (9)
- Aspergillus terreus Species Complex (2021) (9)
- Azole resistance in aspergillosis: The next threat? (2009) (9)
- A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria (2018) (9)
- In Vitro Activities of Amphotericin B, Terbinafine, and Azole Drugs against Clinical and Environmental Isolates of Aspergillus terreus Sensu Stricto (2015) (9)
- Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant Candida parapsilosis Isolates in the Galleria mellonella Model (2020) (9)
- Evaluation of a Modified EUCAST Fragmented-Mycelium Inoculum Method for In Vitro Susceptibility Testing of Dermatophytes and the Activity of Novel Antifungal Agents (2015) (9)
- Comparison of Caspofungin MICs by Means of EUCAST Method EDef 7.1 Using Two Different Concentrations of Glucose (2010) (9)
- Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants. (2015) (9)
- Participating Institutions (2006) (9)
- Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance (2019) (8)
- Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation. (2020) (8)
- Spotted Fever Group – Rickettsiae in the Tyrols: Evidence by Seroepidemiology and PCR (2013) (8)
- Necrotizing mycosis due to Verruconis gallopava in an immunocompetent patient (2015) (8)
- Computed tomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients (2014) (8)
- Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection (2019) (8)
- Antifungal susceptibility testing in Candida species: current methods and promising new tools for shortening the turnaround time (2020) (8)
- Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations. (2015) (7)
- Epidemiology of infections due to multiresistantEnterobacter aerogenes in a University Hospital (1996) (7)
- Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability (2021) (7)
- Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006-2015): Impacts & trends (2019) (7)
- Executive Summary of the 2017 ESCMID -ECMM Guideline for the Diagnosis and Management of Aspergillus Disease (2018) (7)
- Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools (2016) (7)
- Rep-PCR and RAPD-PCR fingerprinting of Aspergillus terreus. (2013) (7)
- Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis (2021) (7)
- Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis (2020) (7)
- Self-disinfecting surfaces and activity against Staphyloccocus aureus ATCC 6538 under real-life conditions. (2017) (7)
- Nosocomial outbreak of extensively drug‐resistant Pseudomonas aeruginosa associated with aromatherapy (2017) (7)
- Update: invasive Pilzinfektionen (2010) (7)
- Dexamethasone Promotes Aspergillus fumigatus Growth in Macrophages by Triggering M2 Repolarization via Targeting PKM2 (2021) (6)
- Which Type of Empiric Antibiotic Therapy is Appropriate? A 20-Year Retrospective Study of Bloodstream Infections in Childhood Cancer (2021) (6)
- Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence Studies (2017) (6)
- COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility (2022) (6)
- ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases. (2012) (6)
- Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice (2018) (6)
- [Epidemiology and prevention of pulmonary aspergillosis in patients with hematological malignancies]. (2004) (5)
- Aspergillus-Derived Galactosaminogalactan Triggers Complement Activation on Human Platelets (2020) (5)
- Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro (2008) (5)
- Can We Achieve Clinical Breakpoints for the Triazoles in Aspergillosis? (2011) (5)
- Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus (2020) (5)
- European confederation of medical mycology expert consult—An ECMM excellence center initiative (2020) (5)
- Helicobacter pylori infection and neopterin (2001) (5)
- Granulomatous encephalitis: protothecosis excluded? (2016) (5)
- Wastewater surveillance of SARS-CoV-2 in Austria: development, implementation, and operation of the Tyrolean wastewater monitoring program. (2022) (5)
- Current evidence for the treatment of invasive fungal infections in immunocompromised patients (2011) (4)
- SARS-CoV-2–infected primary human airway epithelia illustrate mucus hypersecretion (2021) (4)
- Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge (2021) (4)
- Role of Dendritic Cell Subsets on HIV-Specific Immunity (2013) (4)
- Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses (2021) (4)
- Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species (2007) (4)
- Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model (2021) (4)
- Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP‐EBMT, EORTC‐IDG and SEIFEM survey (2020) (4)
- A European prospective invasive mould disease audit (2014) (4)
- Inhibition of Human Immunodeficiency Virus Replication by Cell Membrane-Crossing Oligomers (2012) (4)
- Multidrug- and Cross-Resistant Candida: the Looming Threat (2015) (4)
- Infections caused by Candida krusei in five transplant and two surgical patients. (2009) (4)
- The Environmental Spread of Aspergillus terreus in Tyrol, Austria (2021) (4)
- Complement in fungal infections and complement evasion strategies (2007) (4)
- Standard dosing regimen of liposomal amphotericin B is as effective as a high-loading dose for patients with invasive aspergillosis: AmBiLoad trial (2007) (3)
- Parallel and cross-resistances of clinical yeast isolates determined by susceptibility pattern analysis (2016) (3)
- Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern (2022) (3)
- Mammary candidiasis: molecular-based detection of Candida species in human milk samples (2016) (3)
- Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance? (2022) (3)
- Liposomal amphotericin B—the past (2022) (3)
- Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium (2020) (3)
- Comparison of novel approaches for expedited pathogen identification and antimicrobial susceptibility testing against routine blood culture diagnostics (2021) (3)
- Retrospective case study on the suitability of mid-infrared microscopic imaging for the diagnosis of mucormycosis in human tissue sections (2017) (3)
- Reply to Garzoni and Dumont (2008) (3)
- Influence of Glucose on Candida albicans and the Relevance of the Complement FH-Binding Molecule Hgt1 in a Murine Model of Candidiasis (2022) (3)
- Diagnosing fungal infections in haematology patients—another case of less is more in the clinical setting? (2017) (3)
- Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs) (2018) (3)
- Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis (2021) (3)
- Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts (2020) (3)
- Cluedo - Source identification in a case of septicemia fatality caused by Capnocytophaga canimorsus. (2020) (2)
- Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes. (2022) (2)
- Hypoxia Promotes Danger-Mediated Inflammation via RAGE in Cystic Fibrosis. (2013) (2)
- Advances in the management of fungal infections (2015) (2)
- Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study (2023) (2)
- Why is biopsy of suspected fungal lung lesions necessary?☆ (2013) (2)
- Innate Immune Responses in HIV-Infection (2011) (2)
- Isavuconazole: an orphan drug for treating invasive candidiasis (2016) (2)
- Long‐sleeved medical workers' coats and their microbiota (2018) (2)
- Diagnosing Aspergillosis: The Role of Invasive Diagnostic Interventions (2009) (2)
- In vitro activity of isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (2012) (2)
- Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry (2022) (2)
- Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity (2020) (2)
- Clinical Performance of FXG™: RESP (Asp +) Assay for Aspergillus on Lung and Other Tissue Samples (2008) (2)
- [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine]. (2010) (2)
- Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? (2019) (1)
- The Current State of Laboratory Fungal Diagnostics and Availability of Antifungal Treatment in Africa: A ECMM and ISHAM Survey (2021) (1)
- The In Vitro Activity of Isavuconazole against Conidia and Hyphae of Aspergillus Species and Zygomycetes (2008) (1)
- Austrian Clinical Practice with Anidulafungin in 2008: A Multicenter Survey (2011) (1)
- CROSS-RESISTANCE OF AZOLES, ECHINOCANDINS, FLUCYTOSINE AND AMPHOTERICIN B IN CLINICALLY IMPORTANT HYPHOMYCETES (2014) (1)
- PS1283 CLINICAL IMPLICATIONS OF AZOLE-RESISTANT VERSUS AZOLE-SUSCEPTIBLE INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL MALIGNANCY (CLARITY) – A MULTICENTER STUDY (2019) (1)
- [Antibiotic treatment of nosocomial pneumonia]. (2011) (1)
- [Serological tests for diagnosing fungal infections]. (2007) (1)
- MicroRNAs (miRNAs) In Virology: A Promising Transnational Research Approach (2012) (1)
- The viral make-up makes a world of difference. (2014) (1)
- Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium (2020) (1)
- Investigation of the effect of sustainable magnetic treatment on the microbiological communities in drinking water. (2022) (1)
- Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods (2018) (1)
- Sepsis in Pediatric Cancer: Does Gender Matter? A 20-Year Retrospective Study (2021) (1)
- Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients (2021) (1)
- Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population (2022) (1)
- Multiple colony antifungal susceptibility testing detects polyresistance in clinical Candida cultures: an ECMM Excellence centers study. (2022) (1)
- Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia (2022) (1)
- Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen (2022) (1)
- Clinical Performance of FXGTM: RESP (Asp +) assay for Aspergillus on respiratory specimens (2008) (1)
- Echinocandins and Their Activity against Aspergillus terreus Species Complex: a Novel Agar Screening Method (2021) (1)
- 1462Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study (2014) (1)
- Complement, but Not Platelets, Plays a Pivotal Role in the Outcome of Mucormycosis In Vivo (2023) (1)
- Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity (2019) (1)
- Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA. (2019) (1)
- Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections (2022) (1)
- COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses (2022) (1)
- Immunity of heterologous and homologous boosted or convalescent individuals against Omicron BA.1, BA.2 and BA.4/5 variants. (2023) (1)
- Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro (2019) (1)
- Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections (2017) (0)
- Proposed nomenclature for Pseudallescheria, Scedosporium and related genera (2014) (0)
- Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility (2013) (0)
- Ointments as a source of meticillin-resistant Staphylococcus aureus spread. (2008) (0)
- Bronchoalveolar Lavage Lateral-Flow Device Test For Invasive Pulmonary Aspergillosis In Patients With Hematologic Malignancies And In Solid Organ Transplant Patients: A Multicenter Study (2014) (0)
- Diagnosinginvasivefungal diseases-limitationsof microbiologicaldiagnostic methods (2009) (0)
- Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools (2016) (0)
- Development and validation of a single-step reverse transcriptase rapid loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high- throughput screening of COVID-19 Running title: Rapid diagnosis of COVID-19 by a LAMP assay (2020) (0)
- Online‐Only Abstracts (2011) (0)
- Oral Presentations_Monday (2009) (0)
- Online‐Only Abstracts (2011) (0)
- Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment (2022) (0)
- "Beyond the Guidelines" - Deviations in Adherence to Infection Control Measures in Tyrolean hospitals, Austria. (2022) (0)
- Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients (2018) (0)
- Concentrations and Activity of Amphotericin B in Bile achieved by Lipid-Formulations (2015) (0)
- Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation (2023) (0)
- 2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study (2019) (0)
- Indications that the Antimycotic Drug Amphotericin B Enhances the Impact of Platelets on Aspergillus (2022) (0)
- Extension of an Aerosol Cloud produced by an Ultrasound Cement Removal System (2003) (0)
- The Nationwide Austrian Registry: a prospective data collection on epidemiology; therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients (2020) (0)
- Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technology (2023) (0)
- A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data (2022) (0)
- The changing face of epidemiology of systemic fungal infections (2015) (0)
- Changes in sterol composition of clinically relevant Mucorales due to posaconazole treatment (2017) (0)
- Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp. (2023) (0)
- Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts (2020) (0)
- C albicans FH binding molecule Hgt1p, a low glucose induced membrane protein trafficked to the cell wall impairing phagocytosis (2018) (0)
- DC subsets and their role in HIV infection (2017) (0)
- Interplay between platelets and fungi : at different sites and with different fungal molecules (2017) (0)
- Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees (2022) (0)
- An initiative of the ISHAM Aspergillus terreus working group and ECMM (2013) (0)
- Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods (2023) (0)
- Morphological sectors , impacting on antifungal susceptibility 5 testing and virulence studies 6 7 Running title : Morphological sectors in Aspergillus terreus (2017) (0)
- 5 Innate Immune Responses in HIV-Infection (2012) (0)
- ARTICLES AND COMMENTARIES (2011) (0)
- CASE REPORTS Fusarium verticillioides Abscess of the Nasal Septum in an Immunosuppressed Child: Case Report and Identification of the Morphologically Atypical Fungal Strain (2005) (0)
- 1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study (2020) (0)
- Susceptibility Profiles of Amphotericin B and Posaconazole against Clinically Relevant Mucorales Species under Hypoxic Conditions (2015) (0)
- What paths are open for tackling increasing azole resistance in Aspergillus in the clinic? (2012) (0)
- Control of hospital-acquired infections in Austria (2018) (0)
- Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata (2022) (0)
- Non–Culture-Based Methods for the Diagnosis of Invasive Candidiasis (2011) (0)
- Susceptibility profile of amphotericin B and posaconazole against clinically 1 relevant Mucorales in hypoxia (2014) (0)
- Interlaboratory reproducibility of a touch-transfer assay for the assessment of antimicrobial surfaces. (2023) (0)
- A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients (2018) (0)
- P384 Characterization of the virulence potential of Aspergillus species of section Terrei in Galleria mellonella infection model (2022) (0)
- Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit (2018) (0)
- Propofol and postoperative infections. (1995) (0)
- A project of the European Confederation of Medical Mycology (ECMM) (2012) (0)
- Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis. (2023) (0)
- Guideline Adherence Predicts Survival of Candidemia in Europe: Results from the ECMM Candida III Multinational European Study (2022) (0)
- Erratum to 'High-quality endoscope reprocessing decreases endoscope contamination' [Clinical Microbiology and Infection, Volume 24, Issue 10 (October 2018) Pages 1101.e1-1101.e6]. (2019) (0)
- Immune evasion of pathogenic moulds by acquisition of complement factor H and C4b binding protein (2007) (0)
- Susceptibility Screening of Hyphae-Forming Fungi with a New, Easy, and Fast Inoculum Preparation Method (2012) (0)
- Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5 (2023) (0)
- Effect of reduced oxygen on the antifungal susceptibility of clinically relevant 1 Aspergilli 2 3 Running titel : Hypoxia influences susceptibility of Aspergilli (2014) (0)
- 353. Evaluation of the in vitro activity of amphotericin B used in the liposomal formulation AmBisome against contemporary human fungal pathogens (2022) (0)
- 2104. Susceptibility Trends in Antifungal Resistance (STAR) Study: Preliminary Data from A New Prospective Antifungal Surveillance Study (2019) (0)
- Candida parapsilosis isolates carrying mutations outside of FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance. (2023) (0)
- Correction to: Proposed nomenclature for Pseudallescheria, Scedosporium and related genera (2022) (0)
- Type: Invited PresentationAntifungal stewardship (2014) (0)
- Correction: ColdZyme® protects airway epithelia from infection with BA.4/5 (2023) (0)
- Correction to: Proposed nomenclature for Pseudallescheria, Scedosporium and related genera (2022) (0)
- Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase (2017) (0)
- Correction for Wu et al., “Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling” (2018) (0)
- Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis. (2022) (0)
- Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study (2020) (0)
This paper list is powered by the following services:
